Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cybin Inc
N.CYBN
Alternate Symbol(s):
CYBN
Healthcare
Drug Manufacturers - Specialty & Generic
Psychedelics
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary...
deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NEO:CYBN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Aug 04, 2021 7:44am
News: trading tomorrow on the NYSE….
News here: https://www.businesswire.com/news/home/20210804005381/en/
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Aug 03, 2021 10:34am
News: Offering closed….
$34M in the account. News here: https://www.businesswire.com/news/home/20210803005698/en/
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jul 29, 2021 8:43am
News: listing on NYSE on Aug 5th….
Easier access for US investors. Huge news here: https://www.businesswire.com/news/home/20210728006105/en/Cybin-Receives-Final-Approval-to-Commence-Trading-on-the-NYSE-American-on-or-About-August-5
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jul 29, 2021 8:42am
News: raising $30M via overnight offering….
News here: https://ca.finance.yahoo.com/news/cybin-announces-size-pricing-previously-133400162.html
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jul 29, 2021 8:40am
News: 13th patent update….
News here: https://www.psychedelicnewswire.com/cybin-inc-neo-cybn-otcqb-clxpf-files-patent-adds-new-dimension-to-development-strategy/
(23)
•••
Gordinno
X
View Profile
View Bullboard History
Post by
Gordinno
on Jul 29, 2021 6:26am
NEWS
https://stockhouse.com/news/press-releases/2021/07/28/cybin-receives-final-approval-to-commence-trading-on-the-nyse-american-on-or
(9)
•••
yanks7
X
View Profile
View Bullboard History
Comment by
yanks7
on Jul 28, 2021 6:47pm
RE:RE:Overnight Marketed Public Offering of Common Shares
https://stockhouse.com/news/press-releases/2021/07/28/cybin-announces-size-and-pricing-of-previously-announced-overnight-marketed
(23)
•••
Gordinno
X
View Profile
View Bullboard History
Comment by
Gordinno
on Jul 28, 2021 9:37am
RE:Overnight Marketed Public Offering of Common Shares
Fkin rediculous when they said they had millions in March.Just lining own pockets at expenxse of share holders.Take awhile for this to recover now
(3018)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jul 27, 2021 6:42pm
Overnight Marketed Public Offering of Common Shares
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on
...more
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jul 26, 2021 10:12pm
Analyst: CYBN Buy, $8 USD target….
Read it here: https://hcwco.bluematrix.com/sellside/EmailDocViewer?encrypt=8ff8196d-16bd-4220-8b95-446a8922e7f2&mime=pdf&co=Hcwco&id
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jul 22, 2021 9:16am
News: Conditional approval from NYSE…..
should make it easier for US investors. News here: https://www.businesswire.com/news/home/20210721006001/en/
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jul 13, 2021 8:58am
News: 13th patent filed + new digital platform…
News here: https://www.businesswire.com/news/home/20210713005467/en/
(28)
•••
satchmo6
X
View Profile
View Bullboard History
Comment by
satchmo6
on Jul 08, 2021 4:01pm
RE:Cybin in article by Cannabishempwire.com on psychedelics
THE PR0BLEM------------------ Is the exchange---- now the trolls are using it to their advantage-----so go pound salt B3 PROUD! &
...more
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jul 06, 2021 8:58am
News: Partnering on mental health COE……
News here: https://www.businesswire.com/news/home/20210706005214/en/
(607)
•••
thorgb1
X
View Profile
View Bullboard History
Post by
thorgb1
on Jun 28, 2021 9:35am
News: Positive clinical results……
Should be atopic of discussion at the conference today! News here: https://www.businesswire.com/news/home/20210628005439/en/
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Do you want to stay ahead of the markets? See how DealRoom can help.